Breaking ground in the search for ME/CFS and Long COVID therapies
Thanks to the sustained generosity of the Stafford Fox Medical Research Foundation, Griffith University is pushing the boundaries of medical discovery to improve the lives of those suffering from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID.
Under the leadership of Professor Sonya Marshall-Gradisnik, researchers at the National Centre for Neuroimmunology and Emerging Diseases (NCNED) are making groundbreaking strides in uncovering the biological mechanisms behind these debilitating conditions—fuelling discovery and paving the way for life-changing treatments.
A major milestone is happening now: the first 色情网站n clinical trial investigating low dose naltrexone (LDN) as a potential therapy is currently being conducted for long COVID. A further clinical trial for ME is set to commence soon for participants in Queensland, New South Wales and Victoria.
Conducted in partnership with esteemed collaborators, including the World Health Organization (WHO) Reference Laboratory and Barwon Health, this trial is a direct result of visionary philanthropy and an unwavering commitment to supporting medical progress.
More than $100 million of philanthropy has already been secured to create a brighter future for all.
Donate to our research into vaccines and help us create healthier lives for all
Read more impact stories
Scholarship supports Indigenous women in law
Alicia George, whose passion for human rights and the rights of minorities, is the first recipient of a new scholarship that will nurture the next generation of female Aboriginal and Torres Strait Islander legal professionals.
Deeping our understanding of primary forests
Professor Brendan Mackey’s team are reshaping the perception and conservation of primary forests.
Trialling a groundbreaking Strep A vaccine
A life-saving vaccine is one step closer with scientists at Griffith leading an international partnership to create a Strep A vaccine that effective against the bacteria’s many strains and its resistance to immunity, with human clinical trials underway.
Donate
Your donation can help make a positive difference.